Hangzhou Diagens Biotechnology Co., Ltd. is a medical devices company that develops medical imaging products and services. It operates through segments including Medical Imaging Software and Medical Devices, Technology Licensing, Analysis and Consulting Services, and Others. The company's product portfolio features AI AutoVision, a chromosome karyotype assisted diagnosis and analysis system offering intelligent karyotyping analysis for applications in genetics and hematologic oncology. Additional products include MetaSight, an automatic cell microscopic image scanning system that automates scanning, positioning, image acquisition, and output of chromosome or cell samples for cytogenetics applications such as genetics health, radiation health, and hemato-oncology, as well as KayoFlow, an automatic cell harvester for pre-analytical processing of sample types like peripheral blood, amniotic fluid, and bone marrow. Hangzhou Diagens Biotechnology Co., Ltd. supports advancements in medical diagnostics, particularly in genetic and cellular analysis, serving healthcare professionals in clinical and research settings. Headquartered in Hangzhou, China, it plays a key role in the advanced medical equipment and technology sector.